Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹115 Cr₹85 Cr₹71 Cr₹42 Cr₹44 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹115 Cr based on Mar2023 Standalone results.
Year Revenue
Mar2023₹115 Cr
Mar2022₹85 Cr
Mar2021₹71 Cr
Mar2020₹42 Cr
Mar2019₹44 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2023 ₹115 Cr
35.48
Mar2022 ₹85 Cr
19.55
Mar2021 ₹71 Cr
67.68
Mar2020 ₹42 Cr
-2.65
Mar2019 ₹44 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹253.0 Cr 21.6% 39.2% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

21.6%

39.2%

-0.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses